APA (7th ed.) Citation

Al Abbas, A. I., Zenati, M., Reiser, C. J., Hamad, A., Jung, J. P., Zureikat, A. H., . . . Hogg, M. E. (2020). Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. Annals of surgical oncology, 27(6), 2007-2014. https://doi.org/10.1245/s10434-019-08156-3

Chicago Style (17th ed.) Citation

Al Abbas, Amr I., Mazen Zenati, Caroline J. Reiser, Ahmad Hamad, Jae Pil Jung, Amer H. Zureikat, Herbert J. Zeh, and Melissa E. Hogg. "Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma." Annals of Surgical Oncology 27, no. 6 (2020): 2007-2014. https://doi.org/10.1245/s10434-019-08156-3.

MLA (9th ed.) Citation

Al Abbas, Amr I., et al. "Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma." Annals of Surgical Oncology, vol. 27, no. 6, 2020, pp. 2007-2014, https://doi.org/10.1245/s10434-019-08156-3.